Ascendis Pharma A/S (Nasdaq: ASND) today announced that pivotal Week 52 results from its randomized double-blind, ...
Millions of people worldwide continue to experience lingering symptoms after COVID-19, a condition known as long COVID. These ...
Creatine has gotten a lot of attention for its supposed ability to improve strength and cognitive function. There’s some ...
In a randomized trial, intranasal oxytocin combined with affectionate interactions improved wound healing among healthy ...
Scripted recordings of family members’ voices significantly increased delirium-free days for patients in the ICU who required ...
Multicenter, randomized, controlled study will evaluate Company’s next-generation multichannel TMS technology in reducing ...
News-Medical.Net on MSN
Red meat raises inflammation marker CRP in clinical trials
The review analyzes red meat's effects on inflammatory biomarkers, revealing significant associations with CRP in specific ...
Orpyx Medical Technologies has announced that its sensory insoles, analytics platform and remote monitoring program will be used in a new clinical trial funded by the National Institutes of Health ...
University of Wisconsin-Milwaukee and University at Buffalo investigators report that diabetes fatalism is associated with ...
The drug's recent approval and safety data in women with a history of breast cancer mean there is a new option for women not ...
Researchers sought to determine the most appropriate P2Y12 inhibitor therapy in patients with acute coronary syndrome.
New 48-week results from Johnson & Johnson’s Phase IIIb APEX trial show Tremfya delivers durable symptom improvement, slows radiographic progression, and maintains a consistent safety profile in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback